Participation of patients 65 years of age or older in cancer clinical trials. - Wikidata - awgldk - TriplyDB

Participation of patients 65 years of age or older in cancer clinical trials.

Participation of patients 65 years of age or older in cancer clinical trials.

http://www.wikidata.org/entity/Q48006693

about

An electronic application for rapidly calculating Charlson comorbidity score Quality of Life in elderly patients with cancer Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.Adjuvant medical treatment for breast cancer in elderly and old women The impact of comorbidity on cancer and its treatment Chemotherapy in Elderly Patients with Gastric Cancer Benefits of Minimal Access Surgery in Elderly Patients with Pelvic Cancer Elderly patients' participation in clinical trials Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors Colorectal cancer screening and surveillance in the elderly: updates and controversies Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example Comparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological study Outcomes following local therapy for early-stage breast cancer in non-trial populations An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer Breast cancer in older patients: national cancer registry data.Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths.Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis Systemic therapy in stage IV pancreatic cancer: a population-based analysis using the National Cancer Data Base Age-specific cancer survival in Estonia: recent trends and data quality.Leveraging the power of pooled data for cancer outcomes research Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-up.Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data.Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.Older cancer patients' information and support needs surrounding treatment: An evaluation through the eyes of patients, relatives and professionals.[A meta analysis of doublets versus single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer].Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis.Doublets versus single-agent therapy as first-line therapy for elderly patients with advanced non-small cell lung cancer? A systematic review of randomised controlled trials.Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer Prevention of hip fractures in long-term care: relevance of community-derived data.Incidence of Neutropenia in Veterans Receiving Lung Cancer Chemotherapy: A Comparison of Administrative Coding and Electronic Laboratory Data.Differences in clinical trial patient attributes and outcomes according to enrollment setting.Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients Quality of life changes during the pre- to postdiagnosis period and treatment-related recovery time in older women with breast cancer.Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012 Statewide cancer clinical trial navigation service.The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Cancer treatment disparities in HIV-infected individuals in the United States.The value of observational cohort studies for cancer drugs.

P2860

Q24792436-6F4CE864-3F1B-441F-A71E-843BAB0AACA7 Q24802727-E679C48A-287D-4DA5-A137-2730224F14F2 Q25257182-E8D12A43-5833-4C50-844B-2CF091B6E9DA Q26749063-A7B0C54D-CCCC-4C6C-96C8-98F601555106 Q26764935-7E94E74F-F5D5-4831-9E25-AB3E1F9A5A41 Q26771424-2BA3F445-73BB-4D61-B414-1C93F0BDDF32 Q26771710-C9C97254-7EEF-4844-99EF-FA4452B25ACC Q26775623-75324F11-322F-4770-8506-8672A38BC54F Q26863383-0BD18EF9-2466-4304-89D3-CF976B35C535 Q26998578-17524D6E-9AAC-46B7-BC4B-798FB6EEE30B Q27345076-19A35BF6-EA9E-47B1-B546-E13E997E5379 Q28069620-AAD164E9-7428-4B26-B782-9828C4430396 Q28533341-19BD4D50-964F-457C-AD27-6BBE54968D8B Q28749604-457CA6FC-B5A0-4607-A3AB-5AE4D20DAAC3 Q30519487-F75303F9-AD31-4A79-BA50-F6339000AB8C Q30646156-0F41BBFC-6F06-4B49-978A-F0FF467D9455 Q30822062-87F6900C-576F-4974-8B97-E4874A2B058D Q30897591-7290CD8E-42A0-41B6-BE62-07FA395B08C8 Q30978290-1D16FC25-BC4D-44FA-86C8-01DA8E5A4D0D Q30985736-5179E6C8-350A-41AF-9594-C0DCDEAC1474 Q31119154-DACD3819-CCD9-45E2-9478-1DFF25BD5C50 Q31138212-0BD9A314-8244-40C1-ABB0-2AE994C7F379 Q31155248-1A40A1DC-54DE-4FA3-B193-146CCF45BCEB Q33379936-47AEC632-420E-458E-99E3-579B42B656BA Q33400848-746DF92F-3716-4F2E-BB92-6A2B8046E4B0 Q33401712-5C444A88-75F0-44B1-A923-C6F1D39B663F Q33401852-6C72A890-577E-4336-893A-77D6DAEDCB1D Q33411167-81B7D910-9391-45CB-B0B1-F053BE235549 Q33412728-C87F6A03-E558-4999-A009-28CE62131F47 Q33519035-1CB669C6-C6F5-48ED-836F-78DAED0F2669 Q33546626-483194EE-650E-45E7-B01D-E27DD48A8D58 Q33557215-3359E578-8970-405E-943D-E31435E2F71A Q33627769-790424AD-8E2B-41CF-8E0F-862AFE3B4699 Q33717014-6120B95A-E2B6-473B-9BBA-47E4E90A96D5 Q33717701-A043B19C-89D8-4CC5-A929-761E89F42554 Q33816617-565F2694-1CC2-41BF-8D77-60B055ADDBB6 Q33846172-C85EC9F5-2437-4E1E-8CA7-8D71CCE4B0CD Q33865329-965E8776-8805-461E-B455-A88CBD2C4D63 Q33927996-F9E6D296-C08A-4622-BEE0-77DC66B5019C Q33973945-25A380B6-D07F-4FAC-A990-FE313E25ABE1

P2860

Participation of patients 65 years of age or older in cancer clinical trials.

http://www.wikidata.org/entity/Q48006693

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Participation of patients 65 years of age or older in cancer clinical trials.

@en

Participation of patients 65 years of age or older in cancer clinical trials.

@nl

type

label

Participation of patients 65 years of age or older in cancer clinical trials.

@en

Participation of patients 65 years of age or older in cancer clinical trials.

@nl

prefLabel

Participation of patients 65 years of age or older in cancer clinical trials.

@en

Participation of patients 65 years of age or older in cancer clinical trials.

@nl

P1433

Q48006693-53EB3D4A-A34C-400F-A72F-004FB9ECFF73

P1476

Q48006693-80C61459-C969-4BDA-95A9-D9E5CFED78FD

P2093

Q48006693-3A13A27E-F5DE-4A5B-9BB3-01F79F96B6EE

Q48006693-44348840-3680-4F06-B6EE-B24E66C4A091

Q48006693-75C00636-0F4B-4B4D-BBAE-D3D6F6CBFC5E

Q48006693-7A031D20-7453-40DD-B8FB-90B05BF43F32

Q48006693-84986DCC-6F4A-44BE-95D3-6EDEBBC4B4E7

Q48006693-C9E3087D-1579-4F4F-8B05-32C54C7BA3A9

Q48006693-D372E5F0-2340-4884-A151-CAF88B5854B0

Q48006693-EB5F8F08-94A7-4503-BA28-180B31B5270D

P304

Q48006693-AFF5CE54-357A-4F5D-8751-3292D86A7FF9

P31

Q48006693-8FC1A98A-00B3-4F9C-8FBC-123595E96BDE

P356

Q48006693-E053B215-A1C4-4B91-8B9C-5803E824E33A

P407

Q48006693-6770E45D-FBF9-49B8-AD74-BF4B87F59975

P433

Q48006693-FAB4A667-8263-436F-AD0E-920D23D5403B

P478

Q48006693-0FC70397-9064-4C6F-A812-32B3C954A254

P577

Q48006693-CF4F4F11-1B18-40D8-8F2D-7558D600C570

P698

Q48006693-AE35B913-6162-4797-A9BE-D615B6663DCC

P356

JCO.2003.08.010

P1433

Journal of Clinical Oncology

P1476

Participation of patients 65 years of age or older in cancer clinical trials.

@en

P2093

Dana P Goldman

http://www.w3.org/2001/XMLSchema#string

Edward L Trimble

http://www.w3.org/2001/XMLSchema#string

José J Escarce

http://www.w3.org/2001/XMLSchema#string

Joy H Lewis

http://www.w3.org/2001/XMLSchema#string

Meredith L Kilgore

http://www.w3.org/2001/XMLSchema#string

Michael G Housman

http://www.w3.org/2001/XMLSchema#string

Michael J Montello

http://www.w3.org/2001/XMLSchema#string

Richard Kaplan

http://www.w3.org/2001/XMLSchema#string

P304

1383-1389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2003.08.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12663731

http://www.w3.org/2001/XMLSchema#string